ATYR (aTyr Pharma) Institutional Ownership: 62.23% (As of Jul. 08, 2026)


ATYR aTyr Pharma Inc ATYR
14 GF Score
Price $0.60
GF Value $0.46
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is aTyr Pharma Institutional Ownership?

aTyr Pharma ATYR -7.43% 14 Institutional Ownership is 62.23% as of Jul. 08, 2026. GuruFocus rates ATYR with a GF Score™ of 14/100 and a GF Value™ of $0.46 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, aTyr Pharma's institutional ownership is 62.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, aTyr Pharma's Insider Ownership is 1.07%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, aTyr Pharma's Float Percentage Of Total Shares Outstanding is 86.80%.

aTyr Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for aTyr Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aTyr Pharma Institutional Ownership Chart

aTyr Pharma Historical Data

The historical data trend for aTyr Pharma can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 58.75 58.02 58.50 54.90 54.69 54.88 54.14 54.03 45.26 41.79
ATYR
14GF Score
aTyr Pharma Inc ATYR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aTyr Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 62.23% mean?
aTyr Pharma (ATYR) has a Institutional Ownership of 62.23% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on aTyr Pharma and its competitors.
Is aTyr Pharma's Institutional Ownership too high?
aTyr Pharma's current Institutional Ownership is 62.23%. Overall, aTyr Pharma has a GF Score™ of 14/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does aTyr Pharma's Institutional Ownership compare to DWTX and CNTX?
aTyr Pharma's Institutional Ownership of 62.23% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on aTyr Pharma and its competitors. aTyr Pharma's current Institutional Ownership is 62.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aTyr Pharma stock overvalued right now?
Based on GuruFocus' analysis, aTyr Pharma (ATYR) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.46, compared to a current price of $0.60 — trading 31.4% above its estimated fair value. The current Institutional Ownership is 62.23%. aTyr Pharma's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For aTyr Pharma (ATYR), the current Institutional Ownership is 62.23% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aTyr Pharma (ATYR) Overvalued in 2026?

Based on GuruFocus' analysis, aTyr Pharma stock appears to be overvalued. The current stock price of $0.60 is trading 31.4% above its estimated GF Value™ of $0.46. GuruFocus considers aTyr Pharma to be Significantly Overvalued.

Key valuation signals for ATYR:

  • Institutional Ownership: 62.23%
  • GF Value™: $0.46 vs. price of $0.60 (31.4% above fair value)
  • GF Score™: 14/100 with 4 warning signs

No single metric tells the full story. See the ATYR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aTyr Pharma Business Description

Other Exchanges 471A:Germany
Address 10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
14GF Score

Get the complete analysis for ATYR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price
$0.46
GF Value